Goldman Sachs Makes Positive Comments on CVS (CVS) Ahead of Results
More News related to CVS
- Highlights From CVS's Q4 Conference Call: Issues Mixed Guidance for Q1 and FY10
- Barron's Believes that CVS (CVS), Henry Schein (HSIC), Western Union (WU), and Fiserv (FISV) are Good Plays in a Challenging Economy (PETM, MHS)
- CVS (CVS) Guides Q1, FY10 on It's Call
- CVS Caremark (CVS) Earnings Grow In Q4, Sales Fall Short
- CVS Caremark Reports Record Results in Fourth Quarter and Fiscal 2009
More News related to Analyst Comments
- Morgan Stanley Says Buy Commodities on Recent Dip
- JPMorgan Close to Upgrading UAL, AMR, US Airways; Raises Estimates on UAL Following Traffic Results (UAUA, AMR, LCC, more)
- S&P Revises Credit Outlooks On BofA (BAC) and Citi (C) to Negative, Saying No More Free Govenment Handouts
- S&P Revises Outlook on Citigroup (C) from Stable to Negative
- Wedbush Maintains an 'Outperform' on Electronic Arts (ERTS); Lowers PT & Estimates
Goldman Sachs issued positive comments today on CVS Caremark Corporation (NYSE: CVS) ahead of earnings due on Nov 5, reiterating their Conviction Buy List rating and $40 price target.
The firm sees EPS of $0.64, in-line with the consensus and at the high-end of co guidance; the firm sees the 2009 guidance range of $2.59-$2.64 to at least be maintained and possibly edged higher; and an update on the $2 billion share buyback, which could be approaching an end.
Related Categories
Analyst CommentsStocks Mentioned
+0.00Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
